This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Granulomatous inflammation

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Granulomatous inflammation is a subtype of chronic inflammation. It is characterised by the formation of granulomas. It can be caused by infectious and non-infectious agents:

  • infection:
    • tuberculosis, causing a classical tubercle
    • leprosy
    • syphilis
    • brucellosis
    • cat scratch disease
    • granuloma inguinale
    • Schistosomiasis
    • Cryptococcus neoformans
    • Coccidiodes immitis
  • inorganic material:
    • silica
    • berylium
    • asbestos
    • pneumoconiosis
    • talc
    • zirconium
  • systemic diseases:
    • sarcoidosis
    • rheumatoid arthritis, causing rheumatoid nodules
    • Wegener's granulomatosis
    • Crohn's disease

Granulomatous inflammation is characterised by either a deficiency in:

  • ability to digest and degrade phagocytosed particle
  • activated cell-mediated immunity as witnessed by the frequent occurrence of lymphocytes

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.